Brian Piekos - Sep 9, 2024 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
Sep 9, 2024
Transactions value $
$0
Form type
3
Date filed
9/11/2024, 04:32 PM
Previous filing
Feb 5, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.